cabecera

Condroprotección

Espacio dirigido a profesionales de la salud, dedicado a la prevención, tratamiento e investigación de la artrosis

Multimedia

OARSI 2013 - World Congress on Osteoarthritis

Philadelphia, PA, April 18-21 2013

ADVANCES IN PHARMACOLOGICAL THERAPY IN OSTEOARTHRITIS:
TARGETING DISEASE MODIFICATION


Satellite Lunch Symposium BIOIBERICA
Friday, April 19, 2013, 12:30 – 02:00 pm
Program:

Welcome and introduction
Marc C. Hochberg, MD, MPH


Osteoarthritis: Epidemiological Update: What’s new?
Nigel K Arden, Mbbs, MD, FRCP


Efficacy and Safety of Chondroitin Sulfate: Overview of Recent Randomized Double Blind Clinical Trials
Daniel Uebelhart, MD


Evidence of Disease-Modifying Activity with Chondroitin Sulfate and Glucosamine
Marc C. Hochberg, MD, MPH



Question and answer session


Concluding Remarks
Marc C. Hochberg, MD, MPH


THE ERA OF PERSONALIZED MEDICINE:
NEW TOOLS FOR THE MANAGEMENT OF JOINT AND BONE DISEASES


Satellite Lunch Symposium BIOIBERICA
Saturday, April 20, 2013, 12:30 – 02:00 pm
 
Program:

Welcome and introduction
Ingrid Möller, MD


Predicting outcome in Patients with Osteoarthritis: how far have we got?
Nigel K Arden, MBBS, MD, FRCP


Cartilage damage and in¬ammation biomarkers: early detection tools to prevent and monitor Osteoarthritis Progression
Xavier Chevalier, MD, PhD


Applied genetics of Osteoarthritis: What can we use?
Allen Sawitzke, MD


Arthrosischip®/Arthrotest®: a clinically validated DNA-based Test to Predict Knee Osteoarthritis Progression
Ingrid Möller, MD


Bioiberica′s research projects in Personalized Health Care
Josep Vergés, MD, MSC, PhD


Question and Answer Session


Concluding Remarks
Nigel K. Arden, MBBS, MD, FRCP
Ingrid Möller, MD




* Esta web no está destinada a reportar efectos adversos de los productos de Bioibérica. Si desea reportar efectos adversos, contacte con el departamento de Farmacovigilancia
Copyright © 2018, Bioiberica, S.A. Todos los derechos reservados.